Cg Oncology, Inc.
Clinical trials sponsored by Cg Oncology, Inc., explained in plain language.
-
New Virus-Based therapy offered to bladder cancer patients who failed standard care
Disease control AVAILABLEThis program provides early access to cretostimogene grenadenorepvec, a virus-based therapy, for patients with non-muscle invasive bladder cancer that has not responded to standard BCG treatment. Eligible participants have a specific type of bladder cancer (CIS with or without hi…
Sponsor: CG Oncology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Bladder cancer virus therapy shows promise in Mid-Stage trial
Disease control Recruiting nowThis Phase 2 trial tests a drug called cretostimogene grenadenorepvec in 325 people with high-risk non-muscle-invasive bladder cancer. The drug is a virus that is put directly into the bladder to attack cancer cells. The study looks at how well it works and how safe it is, includ…
Phase: PHASE2 • Sponsor: CG Oncology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC